Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CONMED Corp (CNMD)
|
Add to portfolio |
|
|
|
| Price: |
$145.86
| | Metrics |
| OS: |
30.7
|
M
| |
|
|
| Market cap: |
$4.48
|
B
| |
|
|
|
Net debt:
|
$1.04
|
B
| |
5.8
|
x Debt/EBITDA
|
|
EV:
|
$5.52
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$180
|
M
| |
30.7
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 1,010.6 | 862.5 | 955.1 | 859.6 | 796.4 | 763.5 | 719.2 | 740.1 |
| Revenue growth | 17.2% | -9.7% | 11.1% | 7.9% | 4.3% | 6.2% | -2.8% | -3.0% |
| Cost of goods sold | 442.6 | 402.2 | 430.4 | 390.5 | 365.4 | 355.2 | 337.5 | 336.0 |
| Gross profit | 568.0 | 460.3 | 524.7 | 469.1 | 431.0 | 408.3 | 381.7 | 404.1 |
| Gross margin | 56.2% | 53.4% | 54.9% | 54.6% | 54.1% | 53.5% | 53.1% | 54.6% |
| Selling, general and administrative | 414.8 | 373.8 | 400.1 | 355.6 | 351.8 | 338.4 | 303.1 | 323.5 |
| Research and development | 43.6 | 40.5 | 45.5 | 42.2 | 32.3 | 32.3 | 27.4 | 27.8 |
| EBITA | 143.0 | 80.2 | 111.4 | 94.5 | 68.2 | 57.7 | 63.8 | 65.8 |
| EBITA margin | 14.2% | 9.3% | 11.7% | 11.0% | 8.6% | 7.6% | 8.9% | 8.9% |
| Amortization of intangibles | 33.3 | 34.2 | 32.3 | 23.2 | 21.3 | 20.0 | 12.6 | 13.0 |
| EBIT | 109.7 | 46.0 | 79.1 | 71.3 | 46.9 | 37.7 | 51.2 | 52.8 |
| EBIT margin | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% | 7.1% | 7.1% |
| Pre-tax income | 73.1 | 1.6 | 31.2 | 50.7 | 28.7 | 19.4 | 45.1 | 46.7 |
| Income taxes | 10.6 | -7.9 | 2.6 | 9.8 | -26.8 | 4.7 | 14.6 | 14.5 |
| Tax rate | 14.4% | | 8.3% | 19.3% | | 24.3% | 32.4% | 31.0% |
| Net income | 62.5 | 9.5 | 28.6 | 40.9 | 55.5 | 14.7 | 30.5 | 32.2 |
| Net margin | 6.2% | 1.1% | 3.0% | 4.8% | 7.0% | 1.9% | 4.2% | 4.3% |
| |
| Diluted EPS | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 | $1.09 | $1.16 |
| Shares outstanding (diluted) | 32.2 | 29.5 | 29.5 | 28.9 | 28.2 | 28.0 | 27.9 | 27.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|